Barclays’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-4,828
| Closed | -$256K | – | 4190 |
|
|
2016
Q1 | $256K | Sell |
4,828
-47,283
| -91% | -$2.51M | ﹤0.01% | 1978 |
|
|
2015
Q4 | $5.84M | Buy |
52,111
+38,451
| +281% | +$4.31M | 0.01% | 625 |
|
|
2015
Q3 | $1.6M | Buy |
13,660
+10,756
| +370% | +$1.26M | ﹤0.01% | 1200 |
|
|
2015
Q2 | $223K | Sell |
2,904
-14,187
| -83% | -$1.09M | ﹤0.01% | 2041 |
|
|
2015
Q1 | $974K | Buy |
17,091
+13,021
| +320% | +$742K | ﹤0.01% | 1618 |
|
|
2014
Q4 | $129K | Sell |
4,070
-980
| -19% | -$31.1K | ﹤0.01% | 2565 |
|
|
2014
Q3 | $121K | Sell |
5,050
-3,745
| -43% | -$89.7K | ﹤0.01% | 2557 |
|
|
2014
Q2 | $150K | Sell |
8,795
-11,992
| -58% | -$205K | ﹤0.01% | 2545 |
|
|
2014
Q1 | $416K | Buy |
20,787
+17,467
| +526% | +$350K | ﹤0.01% | 2063 |
|
|
2013
Q4 | $53K | Sell |
3,320
-29,972
| -90% | -$478K | ﹤0.01% | 3354 |
|
|
2013
Q3 | $332K | Buy |
33,292
+27,206
| +447% | +$271K | ﹤0.01% | 2351 |
|
|
2013
Q2 | $34K | Buy |
+6,086
| New | +$34K | ﹤0.01% | 3507 |
|